Filing Details

Accession Number:
0001104659-20-033480
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 20:49:50
Reporting Period:
2020-03-13
Accepted Time:
2020-03-13 20:49:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765695 Christopher Young C/O Akorn, Inc.
1925 West Field Court, Suite 300
Lake Forest IL 60045
Evp, Global Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-13 54,629 $0.56 69,273 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold at $0.5550 per share.
  2. The amount of shares beneficially owned consists of 69,273 unvested Restricted Stock Units (RSUs).